One Year After Trump's Pledge, Medicaid Drug Price Reductions Remain Unclear

This report examines the Trump administration's promise made a year ago to lower Medicaid drug prices. Despite the pledge, it remains uncertain which drugs will see price changes, as implementation depends on individual states opting in. The situation highlights ongoing challenges in achieving drug price reforms within Medicaid.

Originally published by npr